CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 10 enrolled
Drug / intervention
Negative Pressure treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02137447
NCT02137447Phase 4Completed

A Prospective Observational Study of the Use of Negative Pressure Wound in High Risk Surgical Closed Incisions.

Massachusetts General Hospital·interventional·Posted May 13, 2014·Updated Apr 18, 2017

In Brief

A Phase 4 clinical trial evaluating Negative Pressure treatment for High Risk Abdominal Wounds. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the use of Negative Pressure Wound Therapy in high risk surgical wounds to evaluate the rate of surgical site infections (SSIs). Hypothesis: Historically, the average rates of infective complications in surgical wounds types are 7.7% in clean wounds, 15% for contaminated and 35-40% for dirty wounds. The application of Prevena ™ Incision Management System (Kinetic Concepts Inc, San Antonio, TX) is expected to reduce these rates by 50%.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 13, 2014
Enrollment StartMay 1, 2014
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.1 years ago

Interventions

Negative Pressure treatmentdevice